Description

Neurotransmitters + UDH I

Neurotransmitters + UDH II is an advanced urine test panel that evaluates metabolites of key neurotransmitters including serotonin, dopamine, norepinephrine, epinephrine, GABA, glutamate, and histamine, combined with urinary dopamine 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) measurements to provide a detailed assessment of dopamine metabolism and overall nervous system function.

This panel helps identify neurotransmitter imbalances and dopamine pathway alterations linked to neurological, psychiatric, and neurodegenerative disorders. It is useful for patients with mood disorders, ADHD, Parkinson’s disease, chronic fatigue, or sleep disturbances. The test guides personalized treatment strategies involving nutrition, supplements, and lifestyle changes aimed at restoring neurotransmitter balance and optimizing dopamine metabolism.

Categories by Disease

• Mood disorders (depression, anxiety)
• Neurodevelopmental disorders (ADHD, autism spectrum)
• Parkinson’s and other neurodegenerative diseases
• Chronic fatigue syndrome and sleep disorders
• Stress-related hormonal and neurotransmitter dysregulation

Categories by Symptoms

• Anxiety, depression, irritability
• Cognitive difficulties and poor concentration
• Fatigue, low motivation, apathy
• Insomnia and disrupted sleep patterns
• Motor symptoms such as tremors or rigidity

Categories by Lifestyle

• Chronic stress or trauma
• Nutritional deficiencies affecting neurotransmitter synthesis
• Exposure to neurotoxins or environmental toxins
• Medication use influencing dopamine pathways
• Irregular sleep or circadian rhythm disturbances

Categories by Diagnostic Methods

Urine analysis via high-performance liquid chromatography (HPLC) or mass spectrometry quantifying neurotransmitter metabolites including DOPAC and HVA; Provides functional insights into neurotransmitter activity and dopamine metabolism.